1.6.3.5: renalase
This is an abbreviated version!
For detailed information about renalase, go to the full flat file.
Word Map on EC 1.6.3.5
-
1.6.3.5
-
hypertension
-
renin
-
angiotensin
-
renin-angiotensin
-
cardiac
-
catecholamine
-
normotensive
-
cardiovascular
-
arterial
-
hypertrophy
-
sympathetic
-
systolic
-
glomerular
-
antihypertensive
-
proteinuria
-
angiotensin-converting
-
hansd
-
hannover
-
losartan
-
glomerulosclerosis
-
prorenin
-
tgrmren227
-
conscious
-
ii-dependent
-
angiotensinogen
-
endothelin
-
nephrectomized
-
transgene-negative
-
intrarenal
-
renoprotective
-
epoxyeicosatrienoic
-
end-organ
-
perindopril
-
bosentan
-
extra-renal
-
atrasentan
-
bp-lowering
-
aorto-caval
-
dinucleotide-dependent
-
prehypertensive
-
medicine
-
valsartan
-
monogenetic
-
juxtaglomerular
-
mren227
- 1.6.3.5
- hypertension
- renin
- angiotensin
-
renin-angiotensin
- cardiac
- catecholamine
-
normotensive
- cardiovascular
- arterial
- hypertrophy
-
sympathetic
-
systolic
-
glomerular
-
antihypertensive
- proteinuria
-
angiotensin-converting
-
hansd
-
hannover
- losartan
- glomerulosclerosis
- prorenin
-
tgrmren227
-
conscious
-
ii-dependent
- angiotensinogen
- endothelin
-
nephrectomized
-
transgene-negative
-
intrarenal
-
renoprotective
-
epoxyeicosatrienoic
-
end-organ
- perindopril
- bosentan
-
extra-renal
-
atrasentan
-
bp-lowering
-
aorto-caval
-
dinucleotide-dependent
-
prehypertensive
- medicine
- valsartan
-
monogenetic
-
juxtaglomerular
-
mren227
Reaction
Synonyms
alphaNAD(P)H oxidase/anomerase, REN, Ren-1, Ren-2, Ren1, renalase-1, renalase-2, RnlS
ECTree
1.6.3.5 renalaseAdvanced search results
results (
results (Systematic Name
Systematic Name on EC 1.6.3.5 - renalase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
top
SYSTEMATIC NAME 
IUBMB Comments
dihydro-NAD(P):oxygen oxidoreductase (H2O2-forming)
Requires FAD. Renalase, previously thought to be a hormone, is a flavoprotein secreted into the blood by the kidney that oxidizes the 1,2-dihydro- and 1,6-dihydro- isomeric forms of beta-NAD(P)H back to beta-NAD(P)+. These isomeric forms, generated by nonspecific reduction of beta-NAD(P)+ or by tautomerization of beta-NAD(P)H, are potent inhibitors of primary metabolism dehydrogenases and pose a threat to normal respiration.
